Triple-Negative Breast Cancer Subtype Chemosensitive

Share this content:
Triple-Negative Breast Cancer Subtype Chemosensitive
Triple-Negative Breast Cancer Subtype Chemosensitive

WEDNESDAY, Dec. 14, 2016 (HealthDay News) -- For patients with triple-negative breast cancer (TNBC), a BRCA-deficiency (BRCA-D) subtype is chemosensitive, according to a study published online Dec. 13 in PLOS Medicine.

Tingting Jiang, Ph.D., from Yale University in New Haven, Conn., and colleagues performed whole exome sequencing on 29 TNBC cases from the MD Anderson Cancer Center (MDACC) with pathologic complete response (18 patients) or extensive residual disease (11 patients) after neoadjuvant chemotherapy. Data were included from two validation cohorts: 144 cases from The Cancer Genome Atlas (TCGA) and 278 cases from METABRIC.

The researchers found that mutations in the AR- and FOXA1-regulated networks, which involved BRCA1, correlated with significantly higher sensitivity to anthracycline/taxane chemotherapy in the MDACC cohort and significantly better survival outcome in the TCGA TNBC cohort. Tumors of a distinct BRCA-D TNBC subtype were identified; the subtype was characterized by low levels of wild-type BRCA1/2 expression. Significantly better survival was seen with standard-of-care chemotherapy for patients with functionally BRCA-D tumors versus tumors that were not BRCA-D; they also had significantly higher mutation burden and presented clonal neoantigens that correlated with increased immune cell activity. A transcriptional signature of BRCA-D TNBC tumors that correlated with improved survival in the METABRIC dataset was independently validated.

"The comprehensive molecular analysis presented in this study directly links BRCA deficiency with increased clonal mutation burden and significantly enhanced chemosensitivity in TNBC," the authors write.

One author disclosed financial ties to Nuvera Biosciences.

Full Text

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

Extremely Low-Frequency Magnetic Fields Tied to ALS Death

Extremely Low-Frequency Magnetic Fields Tied to ALS Death

Possible association for ALS mortality with occupational exposure to ELF-MFs in men

Increases in Heroin Use in the U.S. Greater Among Whites

Increases in Heroin Use in the U.S. Greater ...

Increase in prevalence of heroin use, heroin use disorder, with increase more pronounced in whites

Contralateral Prophylactic Mastectomy Rates Up Nationwide

Contralateral Prophylactic Mastectomy Rates Up Nationwide

Increase seen in all states from 2004 to 2012, with greatest increases in five contiguous Midwest states

is free, fast, and customized just for you!

Already a member?

Sign In Now »